PAUL GENNARO
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology WEST LONG BRANCH, NJ NPI 1942268412
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NJ ABBVIE INC. All categories
General Payments — all program years on this page
$4,168.38
- Category: General Payments
- Program years: PY2018–2023
- Record count: 270
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,101.30 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,101.30 | 67 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.63 | 9 |
| UCB, Inc. | $153.87 | 10 |
| PFIZER INC. | $153.01 | 13 |
| ARGENX US, INC. | $72.20 | 5 |
| EISAI INC. | $53.08 | 3 |
| Inspire Medical Systems, Inc. | $48.07 | 2 |
| Genentech USA, Inc. | $47.50 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.62 | 2 |
| SK Life Science, Inc. | $37.43 | 2 |
| JAZZ PHARMACEUTICALS INC. | $33.00 | 2 |
| Lundbeck LLC | $32.72 | 2 |
| HARMONY BIOSCIENCES LLC | $30.66 | 2 |
| Neurocrine BioSciences, Inc. | $29.06 | 2 |
| Azurity Pharmaceuticals, Inc. | $26.65 | 1 |
| Biogen, Inc. | $25.94 | 1 |
| Lilly USA, LLC | $18.01 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.94 | 1 |
| Amylyx Pharmaceuticals, Inc. | $16.71 | 1 |
| Amneal Pharmaceuticals LLC | $16.56 | 1 |
| Axsome Therapeutics, Inc. | $15.73 | 1 |
| Celgene Corporation | $15.51 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.96 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.44 | 1 |
By program year
Records — PY2023 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.